Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

(2022) Anthony P. Carnicelli et al.   CIRCULATION

Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension

(2022) Marc Humbert et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review

(2022) Stefano Ballestri et al.   ADVANCES IN THERAPY

Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial

(2022) Saghar Barati et al.   Revista Portuguesa de Cardiologia

Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimens

(2021) Nobutaka Ikeda et al.   HEART AND VESSELS

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension

(2021) Yong-Jian Zhu et al.   Frontiers in Cardiovascular Medicine

ERS Statement on Chronic Thromboembolic Pulmonary Hypertension

(2020) Marion Delcroix et al.   EUROPEAN RESPIRATORY JOURNAL

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis

(2019) Vicky Mai et al.   PLoS One

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

(2019) Stavros V Konstantinides et al.   EUROPEAN HEART JOURNAL

A Multicentre study of anticoagulation in operable chronic thromboembolic pulmonary hypertension

(2019) Katherine Bunclark et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Use of direct oral anticoagulants prevents increase in pulmonary vascular resistance and incidence of clinical worsening in patients with chronic thromboembolic pulmonary hypertension

(2019) Kazuya Hosokawa et al.   THROMBOSIS RESEARCH

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

(2014) N. van Es et al.   BLOOD

Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review

(2014) F. A. Klok et al.   EUROPEAN RESPIRATORY JOURNAL

Chronic thromboembolic pulmonary hypertension: role of medical therapy

(2013) Joanna Pepke-Zaba et al.   EUROPEAN RESPIRATORY JOURNAL

Chronic Thromboembolic Pulmonary Hypertension

(2013) Nick H. Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Assessing bleeding risk in patients taking anticoagulants

(2013) Marwa Shoeb et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding

(2012) Irene M. Lang et al.   EUROPEAN RESPIRATORY JOURNAL